返回 Agenda
Session 7 Track E: The Complex World of Integrated Health Care Systems
Session Chair(s)
Rebecca Vermeulen, RPH
Vice President, Global Patient Networks | PD Medical Affairs
Genentech, A Member of the Roche Group, United States
This session will focus on the future of quality standards and implications for pharmaceutical companies to be involved as a part of solutions and support decision-making that impacts the care of patients. In particular how field based medical teams (i.e. MSLs, MCLs) can work with quality organizations and clinical practice settings to serve as a trusted resource as quality standards, clinical practice guidelines and risk based patient treatment models are being implemented.
Learning Objective : At the conclusion of this session, participants should be able to:
• Describe what quality standards are and the expectations for healthcare practitioners
• Examine implications for implementing quality standards and the care of patients
• Discuss solutions for engaging field based medical teams within the industry
Speaker(s)
Faculty
Michael Dubroff, MD
Genentech, Inc., A Member of the Roche Group, United States
Faculty
James Stephen Dodge, PHARMD, MBA
Merck & Co., Inc., United States
Executive Director, Medical Affairs Health Systems